Consolidated Statements of Stockholders' Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance, beginning at Sep. 30, 2024	$ 239,057	$ 469,969,333	$ (543,284,900)	$ (73,076,510)
Balance, beginning (in shares) at Sep. 30, 2024	23,905,635
Increase (Decrease) in Stockholders' Equity
Sale of common stock, net of issuance costs	$ 10,000	1,726,042		1,736,042
Sale of common stock, net of issuance costs (in shares)	1,000,000
Stock-based compensation expense		3,672,420		3,672,420
Net (loss) income			17,377,614	17,377,614
Balance, ending at Dec. 31, 2024	$ 249,057	475,367,795	(525,907,286)	(50,290,434)
Balance, ending (in shares) at Dec. 31, 2024	24,905,635
Balance, beginning at Sep. 30, 2025	$ 538,873	572,983,229	(605,709,763)	$ (32,187,661)
Balance, beginning (in shares) at Sep. 30, 2025	53,887,233			53,887,233
Increase (Decrease) in Stockholders' Equity
Issuance of common stock in connection with exercise of warrants	$ 4,286	903,055		$ 907,341
Issuance of common stock in connection with exercise of warrants (in shares)	428,571
Sale of common stock, net of issuance costs	$ 102,271	14,774,833		14,877,104
Sale of common stock, net of issuance costs (in shares)	10,227,166
Issuance of common stock in connection with conversion of convertible promissory note	$ 136	30,600		30,736
Issuance of common stock in connection with conversion of convertible promissory note (in shares)	13,600
Stock-based compensation expense		881,150		881,150
Net (loss) income			(23,058,135)	(23,058,135)
Balance, ending at Dec. 31, 2025	$ 645,566	$ 589,572,867	$ (628,767,898)	$ (38,549,465)
Balance, ending (in shares) at Dec. 31, 2025	64,556,570			64,556,570